Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.5500
-0.0050 (-0.90%)
Last updated: Apr 7, 2026, 3:03 PM AEST
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 75.96 million as of April 7, 2026. Its market cap has increased by 31.36% in one year.
Market Cap
75.96M
Enterprise Value
66.53M
Revenue
2.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.55
Market Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 75.96M, an increase of 195.56%. That is a compound annual growth rate of 50.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 75.96M | -8.26% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aroa Biosurgery | 200.38M |
| Lumos Diagnostics Holdings | 168.57M |
| EMVision Medical Devices | 148.70M |
| Epiminder | 133.60M |
| SomnoMed | 129.26M |
| Compumedics | 57.93M |
| HeraMED | 55.44M |
| CleanSpace Holdings | 37.09M |